Skip to content

Ultrasound-guided Prolotherapy, Oxygen-ozone and corticosteroid injection for treatment of knee osteoarthritis

Ultrasound-guided Prolotherapy, Oxygen-ozone and corticosteroid injection for treatment of knee osteoarthritis: A randomized, double-blind, multi-center study.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20151017024572N23
Enrollment
42
Registered
2020-08-01
Start date
2020-08-21
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of knee. Osteoarthritis of knee

Interventions

Intervention 1: Intervention group one: Corticosteroid, 40 mg Methylprednisolone, one time injection inside knee joint at suprapatellar recess. Intervention 2: Intervention group: Intervention group t

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with mild to moderate osteoarthritis of the knee (Kellgren Lawrence grade I, II and III) Knee pain for at least six months

Exclusion criteria

Exclusion criteria: History of knee surgery or fracture History of knee meniscus or ligaments tear (ACL/PCL/MCL/LCL) Pregnancy History of allergic reaction to Corticosteroid, Dextrose or Ozone Infection at the injection site Uncontrolled diabetes History of systemic inflammatory or connective tissue disease History of knee injections in the last three months History of gout Secondary knee osteoarthritis Contraindications of ozone therapy (deficiency G6PD, uncontrolled hyperthyroidism, leukemia)

Design outcomes

Primary

MeasureTime frame
Visual Analog Scale (VAS). Timepoint: Before intervention, 1 and 8 weeks after intervention. Method of measurement: Visual Analogue Scale Questionnaire.

Secondary

MeasureTime frame
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Timepoint: Before intervention and 1, 8 weeks after intervention. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Arash Babaei

Iran University of Medical Sciences

arashbabaie@gmail.com+98 21 4128 9221

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026